[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
[ Fri, Nov 10th 2023 ]: WOPRAI
Tejas Savant Maintained (VCYT) at Sell with Decreased Target to $22 on, Nov 10th, 2023
- 🞛 This publication is a summary or evaluation of another publication
Tejas Savant of Morgan Stanley, Maintained "Veracyte, Inc." (VCYT) at Sell with Decreased Target from $23 to $22 on, Nov 10th, 2023.
Tejas has made no other calls on VCYT in the last 4 months.
There are 3 other peers that have a rating on VCYT. Out of the 3 peers that are also analyzing VCYT, 0 agree with Tejas's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Tejas
- Mike Matson of "Needham" Maintained at Strong Buy with Decreased Target to $30 on, Wednesday, November 8th, 2023
- Matthew Sykes of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $32 on, Monday, October 23rd, 2023
- Mason Carrico of "Stephens & Co." Reiterated at Buy and Held Target at $34 on, Tuesday, October 10th, 2023